Gordon, K.; Foley, P.; Krueger, J.; Pinter, A.; Reich, K.; Vender, R.; Vanvoorden, V.; Madden, C.; Peterson, L.; Blauvelt, A. Efficacy and Safety of Bimekizumab in Patients With Moderate to Severe Plaque Psoriasis: Results from BE READY, a 56-Week Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study With Randomized Withdrawal. J of Skin 2020, 4, s83.